-
581por Ravichandran, Sathyabaarathi, Erra-Diaz, Fernando, Karakaslar, Onur E., Marches, Radu, Kenyon-Pesce, Lisa, Rossi, Robert, Chaussabel, Damien, Pascual, Virginia, Palucka, Karolina, Paust, Silke, Nahm, Moon H., Kuchel, George A., Banchereau, Jacques, Ucar, Duygu“…This first precision vaccinology study for pneumococcal vaccine responses of older adults uncovered novel and distinct baseline predictors that might transform vaccination strategies and initiate novel interventions.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
582“…Thus, strategies and policies to improve pneumococcal vaccine availability and coverage need to be strengthened to achieve maximum benefits of immunization. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
583por de Greef, Peter C., Lanfermeijer, Josien, Hendriks, Marion, Cevirgel, Alper, Vos, Martijn, Borghans, José A. M., van Baarle, Debbie, de Boer, Rob J.“…In the context of pneumococcal conjugate vaccination, we were able to detect robust T-cell expansions in a minority of the donors, which suggests that the T-cell response against the conjugate in the pneumococcal vaccine is small and/or very broad. These results indicate that there is still a long way to go before TCR sequencing can be reliably used as a personal biomarker for vaccine-induced protection. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
584por Buja, Alessandra, Grotto, Giulia, Taha, Mustapha, Cocchio, Silvia, Baldo, Vincenzo“…In terms of the vaccines promoted, 11 studies prompted the influenza vaccine, four prompted the influenza and pneumococcal vaccines, three the pneumococcal vaccine, two the herpes zoster vaccine, one the COVID-19 vaccine and one both the pneumococcal and herpes zoster vaccines. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
585por Ashgar, Sami S., Faidah, Hani, Bantun, Farkad, Jalal, Naif A., Qusty, Naeem F., Darwish, Abdulla, Haque, Shafiul, Janahi, Essam M.“…The key drivers for pneumococcal vaccine development involve high morbidity and mortality in over one million cases, especially in very young children and the elderly. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
586por Quimby, Alexandra E., De Ravin, Emma, Eliades, Steven J., Brant, Jason A., Bigelow, Douglas, Ruckenstein, Michael J.“…Data was collected on receipt of prophylactic antibiotics and/or pneumococcal vaccines during the timeframe between diagnosis and surgical repair. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
587“…CONCLUSION: Streptococcus pneumoniae isolation from nasopharyngeal was found to be in lower proportion in cases as compared to control, though colonization with vaccine serotypes was higher in cases as compared to control. Therefore, pneumococcal vaccine coverage must be increased to prevent community acquired pneumonia.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
588por HogenEsch, Harm, Dunham, Anisa, Hansen, Bethany, Anderson, Kathleen, Maisonneuve, Jean-Francois, Hem, Stanley L“…The goal of this study was to determine the optimal formulation of a killed whole cell pneumococcal vaccine with aluminum-containing adjuvants for intramuscular injection. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
589“…Infections group shown are as follows: poliomyelitis, pertussis, diphtheria, tetanus, and Haemophilus influenzae type b (10), influenza (9), human papillomavirus infection (8), pneumococcal vaccine (6), herpes zoster (4), smallpox (4), hepatitis B (4), etc. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
590“…The findings of this review will contribute to the debate on whether pneumococcal vaccine should be offered to smokers and people who misuse alcohol in addition to other clinically defined risk groups.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
591por Giacomelli, Irai Luis, Steidle, Leila John Marques, Moreira, Frederico Fernandes, Meyer, Igor Varela, Souza, Ricardo Goetten, Pincelli, Mariângela Pimentel“…Regarding non-pharmacological management, 33% of the patients were smokers, only 32% had been advised to receive the flu vaccine, 28% had received pneumococcal vaccine, and only 6.5% of the patients in the B, C, and D categories received pulmonary rehabilitation. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
592por Gómez-Junyent, Joan, Garcia-Vidal, Carolina, Viasus, Diego, Millat-Martínez, Pere, Simonetti, Antonella, Santos, Mª Salud, Ardanuy, Carmen, Dorca, Jordi, Carratalà, Jordi“…CONCLUSIONS: CAP in patients with COPD presents specific characteristics and risk factors for mortality. Prior pneumococcal vaccine has a beneficial effect on outcomes. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
593“…Based on its surface accessibility, role in virulence and ability to elicit protective immunity, we propose that SP0845 may be a potential candidate for a protein-based pneumococcal vaccine.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
594por Brookes, Roger H, Ming, Marin, Williams, Kimberley, Hopfer, Robert, Gurunathan, Sanjay, Gallichan, Scott, Tang, Mei, Ochs, Martina M“…This supports the development of the PhtD candidate as part of a broadly protective pneumococcal vaccine.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
595por Makarewicz, Oliwia, Lucas, Marie, Brandt, Christian, Herrmann, Leonie, Albersmeier, Andreas, Rückert, Christian, Blom, Jochen, Goesmann, Alexander, van der Linden, Mark, Kalinowski, Jörn, Pletz, Mathias W.“…More than 94 capsule types have been described, but only a limited number of capsule types accounted for the majority of IPD cases before the introduction of pneumococcal vaccines. After the introduction of the conjugated pneumococcal vaccine PCV7, which covered the seven most frequent serotypes in IPD in the USA, an increase in IPD caused by non-vaccine serotypes was observed, and serotype 19A, which belongs to sequence type (ST) 199, was among the most prevalent STs. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
596por Kirkham, Lea-Ann S., Wiertsema, Selma P., Corscadden, Karli J., Mateus, Tulia, Mullaney, Gemma L., Zhang, Guicheng, Richmond, Peter C., Thornton, Ruth B.“…Therefore, we compared the capacities of antibodies from otitis-prone (cases) and healthy (controls) children to neutralize pneumolysin, the pneumococcal toxin currently in development as a vaccine antigen, and to opsonize pneumococcal vaccine and nonvaccine serotypes. A pneumolysin neutralization assay was conducted on cholesterol-depleted complement-inactivated sera from 165 cases and 61 controls. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
597por Kolšek-šušteršič, Maja, Beg Krasnič, Andreja, Mioč, Verica, Paragi, Metka, Rifel, Janez“…INTRODUCTION: In Slovenia, there is little data available on pneumococcal vaccination rates and no data on asymptomatic NPCR and serotypes in the population of nursing home residents in comparison to the elderly living in domestic environment, therefore the goal was to gain these data. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
598“…Pneumococcal surface protein A (PspA) is an important virulence factor of pneumococci and has been investigated as a primary component of a capsular serotype-independent pneumococcal vaccine. Thus, we sought to determine the genetic diversity of PspA to explore its potential as a vaccine candidate. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
599por Iijima, Shigeo“…CASE PRESENTATION: We report the case of an 11-month-old female infant who developed fulminant pneumococcal meningitis. The pneumococcal vaccine-unimmunized patient was hospitalized with fever, irritability, and purpura, and was diagnosed as having meningitis, septic shock, and disseminated intravascular coagulation. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
600“…This is illustrated in our case by an undiagnosed monoclonal gammopathy of undetermined significance in an apparently healthy woman with at least three life threatening documented pneumococcal infections in a two-year period and poor pneumococcal vaccine response.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto